1887
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Image-fusion of MR spectroscopic images for treatment planning of gliomas
Rent:
Rent this article for
USD
10.1118/1.2128497
    + View Affiliations - Hide Affiliations
    Affiliations:
    1 Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
    2 Department of Medical Physics, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
    3 Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
    4 Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
    5 Department of Medical Physics, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
    6 Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
    7 Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
    8 Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
    a) Electronic mail: changj@mskcc.org
    Med. Phys. 33, 32 (2006); http://dx.doi.org/10.1118/1.2128497
/content/aapm/journal/medphys/33/1/10.1118/1.2128497
http://aip.metastore.ingenta.com/content/aapm/journal/medphys/33/1/10.1118/1.2128497

Figures

Image of FIG. 1.
FIG. 1.

(a) Illustration of the MRSI data overlaid on one slice of a FLAIR MRI image of a patient with glioma. Inside each square is the corresponding spectrum for that MRSI voxel. This is a screen-dump image generated by GE’s FUNCTOOL software. (b) Illustration of a typical MR spectrum for abnormal brain tumor area. Each peak in the spectrum corresponds to a chemical compound. Labeled for tumor delineation are three major peaks: choline (Cho), creatine (Cr), and N-acetyl aspartate (NAA). For an abnormal brain tumor, the Cho intensity is much higher than that of the Cr or NAA intensity.

Image of FIG. 2.
FIG. 2.

Illustration of the converted screen-dumped MRSI image of Fig. 1(a). Although the image screen dumped by the FUNCTOOL is in DICOM format, it cannot be fused with other images because it is a color image and lacks the slice location and pixel size information in the DICOM header. The color image is converted to gray scale, and the pixel size is added to the DICOM header of the converted image. The bold white box is the user-defined MRS acquisition volume of interest. The “MRSI box” consists of the voxels of the MRSI matrix that were covered by the bold white box; “” and “” are the size (mm) of the displayed MRSI box in the x and y directions, while “” and “” are the number of pixels in the corresponding directions.

Image of FIG. 3.
FIG. 3.

An example of converting (a) the Cho/Cr ratios in an exported text file by GE’s FUNCTOOL software to (b) a Cho/Cr image. The intensity of each voxel in (b) is mapped from the grades of Cho/Cr ratio according to Table I; numbers in (b) indicate the corresponding Cho/Cr grades of the image intensity.

Image of FIG. 4.
FIG. 4.

Demonstration of overlaying a converted MRSI image on a FLAIR MRI image. The pixel values of the MR FLAIR image (left) in the MRSI box are replaced by the converted MRSI image (middle) to produce a merged image (right).

Image of FIG. 5.
FIG. 5.

Fusion protocol summary.

Image of FIG. 6.
FIG. 6.

An example of verifying the position of the MRSI box. The modified screen-dumped MRSI images are fused with the merged MRSI, and the locations of the MRSI box of both images are compared using the spy windows of the BRAINSCAN 5.1 (BrainLAB AG, Heimstetten, Germany) treatment planning system. The position of the MRSI box is iteratively adjusted until the positional difference is less than 0.5 mm.

Image of FIG. 7.
FIG. 7.

Fraction of MRSI voxels for each Cho/Cr grade for low-grade glioma (LGG) and high-grade glioma (HGG). The error bars are one standard deviation.

Image of FIG. 8.
FIG. 8.

(a) The dose distribution on one CT slice of an IMRT test plan using the MRSI defined targets. Three dose levels of corresponding to were planned to cover the three PTVs contoured in blue, green, and yellow, respectively. (b) The DVH of this test plan.

Tables

Generic image for table
TABLE I.

The system used to grade the Cho/Cr for each MRS voxel. The first column lists the Cho/Cr ratio, which is mapped to a grade in the second column. Columns 3, 4, and 5 show the corresponding image intensity, clinical target volume, and dose level for each Cho/Cr grade.

Loading

Article metrics loading...

/content/aapm/journal/medphys/33/1/10.1118/1.2128497
2005-12-19
2014-04-23
Loading

Full text loading...

This is a required field
Please enter a valid email address
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: Image-fusion of MR spectroscopic images for treatment planning of gliomas
http://aip.metastore.ingenta.com/content/aapm/journal/medphys/33/1/10.1118/1.2128497
10.1118/1.2128497
SEARCH_EXPAND_ITEM